1. Home
  2. CDNA vs EEX Comparison

CDNA vs EEX Comparison

Compare CDNA & EEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$21.86

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Emerald Holding Inc.

EEX

Emerald Holding Inc.

HOLD

Current Price

$4.95

Market Cap

979.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
EEX
Founded
1998
2013
Country
United States
United States
Employees
N/A
821
Industry
Medical Specialities
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
979.7M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
CDNA
EEX
Price
$21.86
$4.95
Analyst Decision
Buy
Strong Buy
Analyst Count
6
1
Target Price
$27.60
$7.70
AVG Volume (30 Days)
672.4K
14.8K
Earning Date
04-28-2026
05-12-2026
Dividend Yield
N/A
1.24%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$48,324,000.00
N/A
Revenue This Year
$16.01
$7.49
Revenue Next Year
$11.31
$6.81
P/E Ratio
N/A
$236.96
Revenue Growth
18.93
N/A
52 Week Low
$10.96
$3.32
52 Week High
$23.24
$5.45

Technical Indicators

Market Signals
Indicator
CDNA
EEX
Relative Strength Index (RSI) 64.28 58.48
Support Level $16.63 $4.81
Resistance Level $23.24 $5.02
Average True Range (ATR) 1.39 0.18
MACD 0.36 0.03
Stochastic Oscillator 81.12 72.00

Price Performance

Historical Comparison
CDNA
EEX

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About EEX Emerald Holding Inc.

Emerald Holding Inc is a business-to-business (B2B) event organizer principally in the United States, with operations in the United Kingdom (U.K.), France, and other markets. The company is engaged in three complementary business lines: Connections division consists of a collection of B2B trade show franchises and other live events that provide exhibitors opportunities to engage with buyers and expand their brand's awareness in their industry; the Content division consists of B2B print publications and digital media products that complement existing trade show properties, and the Commerce division provides B2B e-commerce and digital merchandising solutions to manufacturers and retailers. Emerald's key revenue is derived from the Connections business, its only reportable segment.

Share on Social Networks: